Develops medications for rare diseases and COVID-19.
Mar 2026Revenue $16.5M/yrExpenses $34.4M/yr
No trendCash runway ≈ 1 months from Mar 2026
Figures by year
When will Dalrada Technology Group be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Mar 2026, revenue was $16.5M and expenses $34.4M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jun 2025 | $20.3M | $40.8M | −$20.5M |
| Jun 2024 | $19.8M | $46.7M | −$26.8M |
| Jun 2023 | $29.7M | $50.7M | −$21.0M |
| Jun 2022 | $19.3M | $29.7M | −$10.4M |
| Jun 2021 | $3.41M | $12.0M | −$8.57M |
| Jun 2020 | $1.18M | $3.87M | −$2.69M |
| Jun 2019 | $72.2K | $1.12M | −$1.05M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.